Phase II trial of zoledronic acid combined with androgen-deprivation therapy for treatment-naïve prostate cancer with bone metastasis.
about
Phase II trial of zoledronic acid combined with androgen-deprivation therapy for treatment-naïve prostate cancer with bone metastasis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Phase II trial of zoledronic a ...... e cancer with bone metastasis.
@en
Phase II trial of zoledronic a ...... e cancer with bone metastasis.
@nl
type
label
Phase II trial of zoledronic a ...... e cancer with bone metastasis.
@en
Phase II trial of zoledronic a ...... e cancer with bone metastasis.
@nl
prefLabel
Phase II trial of zoledronic a ...... e cancer with bone metastasis.
@en
Phase II trial of zoledronic a ...... e cancer with bone metastasis.
@nl
P2093
P2860
P1476
Phase II trial of zoledronic a ...... e cancer with bone metastasis.
@en
P2093
Atsunobu Esa
Hideyasu Matsuyama
Hiroshi Kajikawa
Hirotsugu Uemura
Kazuhiro Nagao
Masaaki Imanishi
Masahiro Nozawa
Michio Kitagawa
Shigeya Uejima
P2860
P2888
P304
P356
10.1007/S10147-013-0604-Z
P577
2013-08-03T00:00:00Z